Biopharmaceutical
Biotechnology
Cancer Prevention

Geron

$1.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-2.84%) As of 3:19 PM EDT today
-$0.04 (-2.84%) Today

Why Robinhood?

You can buy or sell Geron and other stocks, options, ETFs, and crypto commission-free!

About GERN

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Read More The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.

Employees
17
Headquarters
Menlo Park, California
Founded
1990
Market Cap
265.68M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.43M
High Today
$1.45
Low Today
$1.36
Open Price
$1.45
Volume
698.69K
52 Week High
$6.99
52 Week Low
$0.9547

Collections

Biopharmaceutical
Biotechnology
Cancer Prevention
Pharmaceutical
Health
Medical
Technology

GERN News

ReutersAug 7

Edited Transcript of GERN earnings conference call or presentation 1-Aug-19 8:30pm GMT

1,061

GERN Earnings

-$0.09
-$0.07
-$0.05
-$0.03
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Oct 31, After Hours

Popular Stocks

More GERN News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.